Cargando…

MPC-08 Molecular risk stratification using genome-wide DNA methylation data of standard-risk medulloblastomas treated with 18-Gy craniospinal irradiation

A novel risk stratification of medulloblastoma has been proposed based on retrospective data from patients undergoing standard treatment. However, it remains unclear whether the classification is applicable to patients receiving reduced-dose craniospinal irradiation (CSI). We performed molecular dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irikura, Tomoya, Fukuoka, Kohei, Mori, Makiko, Oshima, Koichi, Arakawa, Yuki, Tanami, Yutaka, Ichimura, Koichi, Nakazawa, Atsuko, Kurihara, Jun, Koh, Katsuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699131/ http://dx.doi.org/10.1093/noajnl/vdaa143.052

Ejemplares similares

MPC-6 Clinical significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18Gy of craniospinal irradiation
por: Fukuoka, Kohei, et al.
Publicado: (2021)

MBRS-21. CLINICAL AGGRESSIVENESS OF TP53-WILD TYPE SONIC HEDGEHOG MEDULLOBLASTOMA WITH MYCN AMPLIFICATION
por: Mitani, Yuichi, et al.
Publicado: (2020)

PEDT-07 RECURRENT MEDULLOBLASTOMA 9 YEARS AFTER THE PRIMARY TUMOR
por: Hiraki, Takamasa, et al.
Publicado: (2019)

ATRT-02. AN INFANTILE PINEAL EMBRYONAL TUMOR SHOWING PATHOLOGICAL FEATURES OF A CNS GANGLIONEUROBLASTOMA IN ADDITION TO SMARCA4 MUTATIONS AND THE METHYLATION PROFILING OF AN ATYPICAL TERATOID/RHABDOID TUMOR
por: Fukuoka, Kohei, et al.
Publicado: (2023)

RARE-39. MOLECULARLY CONFIRMED ATYPICAL CHOROID PLEXUS PAPILLOMA WITH INTRACRANIAL DISSEMINATION
por: Yanagi, Masato, et al.
Publicado: (2020)

PATH-25. GENOME-WIDE METHYLATION ANALYSIS CAN SEGREGATE RADIATION-INDUCED GLIOBLASTOMA FROM LATE RECURRENCE OF MEDULLOBLATOMAS
por: Hiraki, Takamasa, et al.
Publicado: (2020)

MEDB-30. Subclassification of Group 3/4 medulloblastoma as a potential prognostic biomarker to reduce the dose of craniospinal irradiation in patients with metastatic tumors: A Japanese Pediatric Molecular Neuro-Oncology Group study
por: Fukuoka, Kohei, et al.
Publicado: (2022)

ETMR-12. EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: A SINGLE CENTER EXPERIENCE
por: Yoshimura, Sodai, et al.
Publicado: (2020)

MPC-02 REVIEW OF MEDULLOBLASTOMA FOR THE ASSESSMENT OF CONSENSUS IN PATHOLOGICAL DIAGNOSIS USING JPMNG CASES
por: Sasaki, Atsushi, et al.
Publicado: (2019)

Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
por: Fukuoka, Kohei, et al.
Publicado: (2023)

Predictive risk score of respiratory complications in children with mediastinal tumors: A case–control study
por: Honda, Mamoru, et al.
Publicado: (2022)

Preclinical Models of Craniospinal Irradiation for Medulloblastoma
por: Stripay, Jennifer L., et al.
Publicado: (2020)

MPC-08 CLINICOPATHOLOGICAL ANALYSIS OF 12P GAIN IN INTRACRANIAL GERM CELL TUMORS
por: Satomi, Kaishi, et al.
Publicado: (2019)

MBCL-41. LYMPHOHEMATOPOIETIC TOXICITY IDENTIFIED IN PATIENTS WITH MEDULLOBLASTOMA RECEIVING CRANIOSPINAL IRRADIATION
por: Watanabe, Atsuko, et al.
Publicado: (2020)

A Pilot Study of Low-Dose Craniospinal Irradiation in Patients With Newly Diagnosed Average-Risk Medulloblastoma
por: Minturn, Jane E., et al.
Publicado: (2021)

MBCL-14. A STUDY OF LOW-DOSE CRANIOSPINAL RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AVERAGE-RISK MEDULLOBLASTOMA
por: Mochizuki, Aaron, et al.
Publicado: (2020)

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma
por: McCabe, Martin G., et al.
Publicado: (2011)

Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma
por: Napieralska, Aleksandra, et al.
Publicado: (2018)

High dose craniospinal irradiation as independent risk factor of permanent alopecia in childhood medulloblastoma survivors: cohort study and literature review
por: Satragno, C., et al.
Publicado: (2022)

Comparison of therapeutic dosimetric data from passively scattered proton and photon craniospinal irradiations for medulloblastoma
por: Howell, Rebecca M, et al.
Publicado: (2012)

Effects of vertebral-body-sparing proton craniospinal irradiation on the spine of young pediatric patients with medulloblastoma
por: MacEwan, Iain, et al.
Publicado: (2017)

Radiation Induced Multiple Skin Neoplasms Following Craniospinal Irradiation for Medulloblastoma. A Case Report
por: Ali, Ahmed Amer Osman, et al.
Publicado: (2020)

MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
por: Erker, Craig, et al.
Publicado: (2022)

XRT-07. LATE-ONSET LYMPHOPENIA DURING CRANIOSPINAL RADIATION IS ASSOCIATED WITH AN INCREASED RISK OF TUMOR RECURRENCE IN NEWLY-DIAGNOSED PEDIATRIC MEDULLOBLASTOMA
por: Lindsay, Holly, et al.
Publicado: (2023)

Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma
por: Suzuki, Shunsuke, et al.
Publicado: (2020)

MON-458 Radiological Alterations Of The Hypothalamic-pituitary Region After Craniospinal Irradiation For Medulloblastoma During Childhood.
por: van Ommen, Corinde, et al.
Publicado: (2019)

Craniospinal Irradiation in Medulloblastoma using High Energy Medical Linear Accelerator: an Innovative Approach to Planning Technique
por: Gurjar, O.P., et al.
Publicado: (2019)

Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison
por: Pollul, Gerhard, et al.
Publicado: (2020)

MBCL-28. LONG-TERM FOLLOW-UP RESULTS OF REDUCED DOSE CRANIOSPINAL RADIOTHERAPY AND TANDEM HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH HIGH-RISK MEDULLOBLASTOMA
por: Lee, Ji Won, et al.
Publicado: (2020)

Clinical and molecular stratification of disease risk in medulloblastoma
por: Gilbertson, R, et al.
Publicado: (2001)

A Simplified Supine Technique Expedites the Delivery of Effective Craniospinal Radiation to Medulloblastoma – Comparison with Other Techniques in the Literature
por: Tai, Patricia, et al.
Publicado: (2015)

Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis
por: Cox, Maurice C., et al.
Publicado: (2015)

Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis
por: Öztunali, Anil, et al.
Publicado: (2021)

MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021)

MPC-19 DIAGNOSTIC APPROACH IN HISTOPATHOLOGICALLY CHALLENGING CASES IN KYOTO UNIVERSITY HOSPITAL
por: Takeuchi, Yasuhide, et al.
Publicado: (2022)

MPC construction techniques
Publicado: (1971)

MPC-11 IDH1/2 MUTATIONS ARE ASSOCIATED WITH SEIZURE ONSET AND VETRY IMAGING IN PATIENTS WITH DIFFUSE GLIOMA VISUALIZING 2-HYDROXYGLUTARATE BY MASS SPECTRUM
por: Ohno, Makoto, et al.
Publicado: (2019)

BIOL-08. IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA
por: Kunhiraman, Haritha, et al.
Publicado: (2021)

BIOL-08. RADIATION DRIVES METASTASIS IN MEDULLOBLASTOMA THROUGH AN INFLAMMATORY PROCESS
por: Nor, Carolina, et al.
Publicado: (2023)

Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification
por: Cho, Hee Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eil8k8v78p90vr4qmasuist5cs